1. Home
  2. BOLD vs MNY Comparison

BOLD vs MNY Comparison

Compare BOLD & MNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • MNY
  • Stock Information
  • Founded
  • BOLD 2018
  • MNY 2014
  • Country
  • BOLD United States
  • MNY Singapore
  • Employees
  • BOLD N/A
  • MNY N/A
  • Industry
  • BOLD
  • MNY
  • Sector
  • BOLD
  • MNY
  • Exchange
  • BOLD Nasdaq
  • MNY Nasdaq
  • Market Cap
  • BOLD 30.3M
  • MNY 31.9M
  • IPO Year
  • BOLD 2024
  • MNY N/A
  • Fundamental
  • Price
  • BOLD $1.09
  • MNY $1.04
  • Analyst Decision
  • BOLD Buy
  • MNY
  • Analyst Count
  • BOLD 3
  • MNY 0
  • Target Price
  • BOLD $4.00
  • MNY N/A
  • AVG Volume (30 Days)
  • BOLD 367.5K
  • MNY 244.3K
  • Earning Date
  • BOLD 08-11-2025
  • MNY 06-13-2025
  • Dividend Yield
  • BOLD N/A
  • MNY N/A
  • EPS Growth
  • BOLD N/A
  • MNY N/A
  • EPS
  • BOLD N/A
  • MNY N/A
  • Revenue
  • BOLD N/A
  • MNY $71,649,746.00
  • Revenue This Year
  • BOLD N/A
  • MNY $31.98
  • Revenue Next Year
  • BOLD N/A
  • MNY $10.97
  • P/E Ratio
  • BOLD N/A
  • MNY N/A
  • Revenue Growth
  • BOLD N/A
  • MNY N/A
  • 52 Week Low
  • BOLD $1.00
  • MNY $0.55
  • 52 Week High
  • BOLD $4.72
  • MNY $1.88
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • MNY 72.14
  • Support Level
  • BOLD N/A
  • MNY $0.66
  • Resistance Level
  • BOLD N/A
  • MNY $1.10
  • Average True Range (ATR)
  • BOLD 0.00
  • MNY 0.09
  • MACD
  • BOLD 0.00
  • MNY 0.04
  • Stochastic Oscillator
  • BOLD 0.00
  • MNY 86.36

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About MNY MoneyHero Limited

MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services. Geographically it operates in Singapore, Hong Kong, Taiwan, Malaysia and the Philippines.

Share on Social Networks: